<?xml version="1.0" encoding="UTF-8"?>
<list>
  <sentences>
    <s path="[OANC]/data/written_2/technical/biomed/1471-2407-2-18.anc" start="12055" end="12060" sStart="11985" offset="70" sid="r7.1.use.v.0334" wn="1" wnkey="use%2:34:01::" text="Spectrophotometrical absorbency of the samples was measured using an UV-visible Recording Spectrophotometer with wavelength of 550-690 nm." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2407-2-18.anc" start="2602" end="2606" sStart="null" offset="127" sid="r7.1.use.v.0796" wn="1" wnkey="use%2:34:01::" text="To verify whether decreased levels of functional M6P/IGF2R can provide a growth advantage for cancer cells, we used viral and ribozyme strategies to reduce the expression of M6P/IGF2R in human breast cancer cells and then examined the effect on growth and apoptosis of these cells." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1471-2407-2-18.anc" start="11170" end="11175" sStart="null" offset="0" sid="null" wn="1" wnkey="time%1:11:00::" text="Following the incubation, the cells were washed 5 &lt;b&gt;times&lt;/b&gt; with ice-cold PBS and subjected to enzyme activity assay as described above." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2407-2-18.anc" start="15774" end="15779" sStart="null" offset="82" sid="r7.serve.v.0382" wn="1" wnkey="serve%2:42:03::" text="A primer specific for human ?-actin was added to a parallel reaction to serve as an internal standard." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2407-2-18.anc" start="18003" end="18009" sStart="null" offset="31" sid="r8.number.n.0393" wn="1" wnkey="number%1:07:00::" text="These results confirm that the number of functional M6P/IGF2R in ribozyme-treated cells was reduced." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2407-2-18.anc" start="12177" end="12183" sStart="null" offset="33" sid="r8.number.n.0335" wn="1" wnkey="number%1:07:00::" text="In addition, the total number of viable cells in each treatment group was counted by a trypan blue exclusion method using a hemocytometer." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2407-2-18.anc" start="6883" end="6889" sStart="null" offset="77" sid="r9.normal.j.0615" wn="3" wnkey="normal%3:00:03::" text="After 24 hrs of incubation, the infection medium was replaced with normal (10% FBS) culture medium." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2407-2-18.anc" start="2416" end="2421" sStart="null" offset="101" sid="r9.level.n.0273" wn="1" wnkey="level%1:07:00::" text="Thus, further studies that address the relationship between the functional M6P/IGF2R level and cell growth activity are needed." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2407-2-18.anc" start="18821" end="18828" sStart="null" offset="252" sid="r10.control.n.0993" wn="4" wnkey="control%1:09:02::" text="Assessment of cell proliferative activity by MTT assay and counting of viable cells (data not shown) indicated that the number of MCF-7 cells in ribozyme-expressing cultures was significantly higher than that in control cultures (Fig." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2407-2-18.anc" start="19557" end="19564" sStart="null" offset="21" sid="r10.control.n.0569" wn="3" wnkey="control%1:04:02::" text="6, a large number of control cells underwent apoptosis, as indicated by morphological changes (small round shape) and bright blue nuclear staining." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2407-2-18.anc" start="3997" end="4004" sStart="null" offset="83" sid="r10.control.n.0182" wn="1" wnkey="control%1:07:00::" text="Another viral vector, pAd-GFP, which carries the GFP gene only under the control of the CMV promoter, was generated and used as a control vector." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2407-2-18.anc" start="115" end="121" sStart="null" offset="72" sid="r10.common.j.0963" wn="4" wnkey="common%5:00:00:familiar:02" text="With one million new cases each year, breast cancer is the most common cancer among women and is the leading cause of death in women 30 to 70 years of age in the world." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2407-2-18.anc" start="690" end="696" sStart="null" offset="216" sid="r10.common.j.0968" wn="3" wnkey="common%5:00:00:shared:00" text="Numerous studies have shown that polypeptide growth factors such as insulin-like growth factors (IGFs) are mitogens for breast cancer cells [ 6 7 8 9 ] . The IGF-I and IGF-II signal through a common tyrosine kinase receptor, the insulin-like growth factor 1 receptor (IGF1R), and have mitogenic and cell survival actions that may promote tumor development." />
  </sentences>
</list>